178 related articles for article (PubMed ID: 33764266)
1.
Brice Landry K; Tariq S; Malik A; Sufyan M; Ashfaq UA; Ijaz B; Shahid AA
J Biomol Struct Dyn; 2022 Oct; 40(17):7829-7851. PubMed ID: 33764266
[No Abstract] [Full Text] [Related]
2. Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from
Patil VS; Harish DR; Vetrivel U; Roy S; Deshpande SH; Hegde HV
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164341
[No Abstract] [Full Text] [Related]
3. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.
Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R
Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163
[TBL] [Abstract][Full Text] [Related]
4. Molecular Docking and Pharmacoinformatics Studies Reveal Potential Phytochemicals Against HCV NS5B Polymerase.
Khalid H; Ashfaq UA
Comb Chem High Throughput Screen; 2022; 25(2):335-346. PubMed ID: 33371844
[TBL] [Abstract][Full Text] [Related]
5. Studies of the symmetric binding mode of daclatasvir and analogs using a new homology model of HCV NS5A GT-4a.
Saad KA; Eldawy MA; Elokely KM
J Mol Model; 2022 Dec; 29(1):25. PubMed ID: 36580076
[TBL] [Abstract][Full Text] [Related]
6. Antiviral phytochemicals identification from Azadirachta indica leaves against HCV NS3 protease: an in silico approach.
Ashfaq UA; Jalil A; Ul Qamar MT
Nat Prod Res; 2016 Aug; 30(16):1866-9. PubMed ID: 26274064
[TBL] [Abstract][Full Text] [Related]
7. Screening and molecular docking of selected phytochemicals against NS5B polymerase of hepatitis c virus.
Mustafa G; Majid M; Ghaffar A; Yameen M; Samad HA; Mahrosh HS
Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2317-2322. PubMed ID: 33832906
[TBL] [Abstract][Full Text] [Related]
8. The Life Cycle and in silico Elucidation of Non-structural Replicating Proteins of HCV Through a Pharmacoinformatics Approach.
Tahir RA; Mughal S; Nazir A; Noureen A; Jawad A; Waqas M; Sehgal SA
Comb Chem High Throughput Screen; 2022; 25(4):689-701. PubMed ID: 33596796
[TBL] [Abstract][Full Text] [Related]
9. Computer-aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies.
Qaddir I; Rasool N; Hussain W; Mahmood S
J Vector Borne Dis; 2017; 54(3):255-262. PubMed ID: 29097641
[TBL] [Abstract][Full Text] [Related]
10. Phytochemical profiling and antiviral activity of Ajuga bracteosa, Ajuga parviflora, Berberis lycium and Citrus lemon against Hepatitis C Virus.
Yousaf T; Rafique S; Wahid F; Rehman S; Nazir A; Rafique J; Aslam K; Shabir G; Shah SM
Microb Pathog; 2018 May; 118():154-158. PubMed ID: 29571723
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study.
Rehman S; Ijaz B; Fatima N; Muhammad SA; Riazuddin S
Biomed Pharmacother; 2016 Oct; 83():881-891. PubMed ID: 27513212
[TBL] [Abstract][Full Text] [Related]
12. Identification of phytochemicals from
Moharana M; Pattanayak SK; Khan F
J Biomol Struct Dyn; 2023 Jul; 41(11):5328-5344. PubMed ID: 35694813
[TBL] [Abstract][Full Text] [Related]
13. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
[TBL] [Abstract][Full Text] [Related]
14. Retinoid BMS411 (4-{[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl) carbonyl] amino} benzoic acid), a potential inhibitor of NS5A protein of hepatitis C virus, a candidate for combined therapy of hepatitis C infection.
Ibrahim S; Asad MJ; Mahmood RT; Wattoo FH; Akhter S; Shahwar D
Acta Virol; 2017; 61(2):204-211. PubMed ID: 28523927
[TBL] [Abstract][Full Text] [Related]
15.
Naik HN; Kanjariya D; Parveen S; Meena A; Ahmad I; Patel H; Meena R; Jauhari S
J Biomol Struct Dyn; 2024 Jul; 42(10):5415-5427. PubMed ID: 37394798
[TBL] [Abstract][Full Text] [Related]
16. Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A.
Sun JH; O'Boyle DR; Fridell RA; Langley DR; Wang C; Roberts SB; Nower P; Johnson BM; Moulin F; Nophsker MJ; Wang YK; Liu M; Rigat K; Tu Y; Hewawasam P; Kadow J; Meanwell NA; Cockett M; Lemm JA; Kramer M; Belema M; Gao M
Nature; 2015 Nov; 527(7577):245-8. PubMed ID: 26536115
[TBL] [Abstract][Full Text] [Related]
17. Molecular Docking and
Muhammad I; Niaz S; Gul E Nayab ; Hussain A; Ahmad S; Rahman N; Khan H; Ali A
Curr Comput Aided Drug Des; 2021; 17(7):946-956. PubMed ID: 32532195
[TBL] [Abstract][Full Text] [Related]
18. Aeginetia indica Decoction Inhibits Hepatitis C Virus Life Cycle.
Lin CW; Lo CW; Tsai CN; Pan TC; Chen PY; Yu MJ
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29315273
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Computational Analysis for the Binding Modes of Hepatitis C Virus NS5A Inhibitors: The Question of Symmetry.
Ahmed M; Pal A; Houghton M; Barakat K
ACS Infect Dis; 2016 Nov; 2(11):872-881. PubMed ID: 27933783
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
